Approval · Notice of Compliance 26971 · 2021
DAPTOMYCIN FOR INJECTION: Notice of Compliance 26971
Issued November 4, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26971
- Date
- November 4, 2021
- Company
- Dr Reddys Laboratories Ltd
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Addition of alternate drug product manufacturing site
- Canadian reference product
- CUBICIN (Cubist Pharmaceuticals Llc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DAPTOMYCIN FOR INJECTION | Not yet assigned | — |
Medicinal ingredients
- DAPTOMYCIN 500 MG per VIAL